CRISPR THERAPEUTICS AG's ticker is CRSP and the CUSIP is H17182108. A total of 444 filers reported holding CRISPR THERAPEUTICS AG in Q1 2022. The put-call ratio across all filers is 0.99 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $2,477,971 | -26.9% | 54,786 | -34.3% | 0.22% | -20.3% |
| Q4 2022 | $3,390,779 | -12.3% | 83,414 | +41.0% | 0.27% | -17.4% |
| Q3 2022 | $3,867,000 | +0.1% | 59,175 | -6.9% | 0.33% | +0.3% |
| Q2 2022 | $3,863,000 | -67.7% | 63,569 | -66.7% | 0.33% | -65.2% |
| Q1 2022 | $11,969,000 | -11.1% | 190,685 | +7.3% | 0.94% | +9.2% |
| Q4 2021 | $13,471,000 | – | 177,769 | – | 0.86% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Versant Venture Management, LLC | 498,558 | $27,989,046 | 33.20% |
| Gilfoyle Management LLC | 100 | $4,842 | 15.90% |
| NEA Management Company, LLC | 1,587,854 | $89,142,124 | 6.80% |
| ARK Investment Management | 7,338,447 | $411,980,394 | 2.73% |
| Nikko Asset Management Americas, Inc. | 3,533,357 | $198,327,328 | 2.09% |
| Del-Sette Capital Management, LLC | 33,661 | $1,889,729 | 1.79% |
| Ikarian Capital, LLC | 200,000 | $11,228,000 | 1.79% |
| Ikarian Capital, LLC | 200,000 | $11,228,000 | 1.79% |
| Merlin Capital, Inc | 8,802 | $494,144 | 1.67% |
| Green Alpha Advisors, LLC | 34,373 | $1,929,700 | 1.27% |